IgE multiple myeloma

Leukemia and Lymphoma

Volumn 32, Issue 5-6, 1999, Pages 597-603

  Macro, Margaret ^a,b   Andre I ^a   Comby, E ^a   Cheze S ^a   Chapon, F ^a   Ballet, J J ^a   Reman, O ^a   Leporrier, M ^a   Troussard, X ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b CHU Clemenceau   (France)

Author keywords

Bone densitometry; IgE; Magnetic resonance imaging; Multiple myeloma; Osteoporosis

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; IMMUNOGLOBULIN E; MELPHALAN; PAMIDRONIC ACID; PREDNISONE;

AGED; ARTICLE; BONE DENSITY; BONE MINERAL; CASE REPORT; DENSITOMETRY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LUMBAR SPINE; MULTIPLE MYELOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA CELL; PLASMACYTOMA; PRIORITY JOURNAL;

EID: 0033054204     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199909058419     Document Type: Article

References (42)

1. Johansson SGO, Bennich H (1967) Immunological studies of an atypical (myeloma) immunoglobulin. Immunology, 13, 381-394.
2. Kyle RA (1975) Multiple myeloma. Review of 869 cases. Mayo Clin Proc, 50, 29-40.
3. Buckley RH, Wray BB, Belmaker EZ (1972) Extreme hyper-immunoglobulin E and undue susceptibility to infection. Pediatrics, 49, 59-70.
4. Alexander RL Jr, Roodman ST, Petruska PJ, Tsai CC, Janney CG (1992) A new case of IgE myeloma. Clin Chem, 38, 2328-2332.
5. Allevato PA, Deegan MJ, Chu JW, Perry MB, Barth CL (1984) A case of IgE myeloma : methodology and review of the literature. Henry Ford Hospital Med J, 32, 134-141.
6. Bomchil G, Becherini JO (1980) Mieloma IgE de evolucion prolongada. Sangre, 25, 503-506.
7. Bouvier M, Creyssel R, Lejeune E, Coeur P, Daumont A (1978) Aspect clinique du myélome IgE. A propos d'une observation personnelle et d'une revue de la littérature. Revue Rhum, 45, 185-192.
8. Chiyoda S, Morikawa T, Tsukasaki K, Nakajima Y (1989) An autopsy case of IgE myeloma. Jpn J Clin Hematol, 30, 686-690.
9. Dammaco F, Miglietta A, Tribalto M, Mandelli F, Bonomo L (1980) The expanding spectrum of clinical and laboratory features of IgE myeloma (Report of a case and review of the literature). La Ricerca Clin Lab, 10, 583-590.
10. Endo T, Okumura H, Kikuchi K, Munakata J, Otake M, Nomura T, Asakawa H (1981) Immunoglobuline (IgE) multiple myeloma. A case report and review of the literature. Am J Med, 70, 1127-1132.
11. Fishkin BG, Orloff N, Scaduto LE, Borucki DT, Spiegelberg HL (1972) IgE multiple myeloma : a report of the third case. Blood, 39, 361-367.
12. Gallango ML, Suinaga R, Ramirez M (1988) IgE pyroglobulinemia in multiple myeloma. Clin Chim Acta, 176, 151-156.
13. Hegewisch S, Mainzer K, Braumann D (1987) IgE myelomatosis. Presentation of a new case and summary of literature. Blut, 55, 55-60.
14. Hiramatsu S, Yoshitake J, Hujita T, Nagai H, Inai S, Senda N (1975) A case of IgE myeloma in Japan. Clin Immunol, 7, 1067.
15. Invernizzi F, Monti G, Caviglia AG, Meroni P, Zanussi C (1991) A new case of IgE myeloma. Acta Haematol, 85, 41-44.
16. Knedel M, Fateh-Moghadam A, Edel H, Bartl R, Neumeier D (1976) Multiples myelom mit monoklonaler IgE-Gammopathie. Dtsch Med Wochenschr, 101, 496-499.
17. Lawlor E, Collins DM, O Connor FB (1986) A case of IgE myeloma. Clin Chim, 32, 697.
18. Ludwig H, Vormittag W (1980) "Benign" monoclonal IgE gammopathy. Br Med J, 281, 539-540.
19. Mc Lachlan R, Grigg AP, Cornell FN, Harris RA, Woodruff RK (1988) Demonstration of monoclonal IgE by isoelectric focusing : first report case of IgE myeloma in Australia. Clin Chim, 34, 2168-2171.
20. Mills RJ, Fahie-Wilson MN, Carter PM, Hobbs JR (1976) IgE myelomatosis. Clin Exp Immunol, 23, 228-232.
21. Ogawa M, Kochwa S, Smith C, Ishizaka K, McIntyre OR (1969) Clinical aspects of IgE myeloma. N Engl J Med, 281, 1217-1220.
22. Proctor SJ (1984) Hyperviscosity syndrome in IgE myeloma. Br Med J, 289, 1112.
23. Rogers JS, Spahr J, Judge DM, Varano LA, Eyster ME (1977) IgE myeloma with osteoblastic lesions. Blood, 49, 295-299.
24. Sala P, Tonutti E, Ruscio M, Colle R, Antonutto G, Falconieri G (1981) IgE myeloma. Report of a new case and review of the literature. Haematologica, 66, 787-795.
25. Stefani DV, Mokeeva RA (1972) Two occurrences of the rare form of myeloma illness (type D and E). Probl Haematol Blood Transf USSR, 6, 44-47.
26. Vaerman JP (1979) A new case of IgE myeloma ending with renal failure. J Clin Lab Immunol, 2, 343-348.
27. Van Wijk HJ, Kerckaert OL, Van Helden HPT (1986) Immunoglobulin E myeloma. Case report and review of the literature. Neth J Med, 29, 196-200.
28. Vladutiu AO, Kohli RK, Prezyna AP (1976) Monoclonal IgE with renal failure. Am J Med, 61, 957-962.
29. Weiner E, DiCamelli R, Showel J, Osmand AP, Sassetti RJ, Gewurz H (1976) IgE myeloma presenting with classical myeloma features. J Allergy Clin Immunol, 58, 373-380.
30. West NC, Smith AM, Ward R (1983) IgE myeloma associated with plasma cell leukaemia. Postgrad Med J, 59, 784-785.
31. Zavazal V, Sach J, Rozprimova L, Brumelova V (1978) An unusual case of IgE myeloma. Allergol Immunopathol 6 : 423-426.
32. Bjorkstrand B, Ljungman P, Brandt L, Gahrton G, et al (1995) Autologous stem cell transplantation in myeloma. EBMT registry data. Bone Marrow Transplant, 15, S2, 12.
33. Macro M, Troussard X, Galateau F, Reman O, Leporrier M, Loyau G (1989) Myélome ostéocondensant diffus avec localisation thyroïdienne. Revue Rhum, 56, 613-620.
34. Mariette X, Khalifa P, Ravaud P, Frija J, Laval-Jeantet M, Chastang C, Brouet JC, Fermand JP (1992) Bone densitometry in patients with multiple myeloma. Am J Med, 93, 595-598.
35. Bataille R, Chappard D, Marcelli C, Dessauw P, Sany J, Baldet P, Alexandre C (1989) Mechanisms of bone destruction in multiple myeloma : the importance of an unbalanced process in determining the severity of lytic bone disease. J Clin Oncol, 7, 1909-1914.
36. Alsina, M., Boyce, B., Devlin, R.D., Anderson, J.L., Craig, F., Mundy, G.R., Roodman, G.D. (1996) Development of an in vivo model of human multiple myeloma bone disease. Blood, 87, 1495-1501.
37. Mariette X, Bergot C, Ravaud P, Roux C, Laval-Jeantet M, Brouet JC, Fermand JP (1995) Evolution of bone densitometry in patients with myeloma treated with conventional or intensive therapy. Cancer, 76, 1559-1563.
38. Berenson JR, Lichtenstein A, Porter L, Dimopoulos MA, Bordoni R, George S, Lipton A, Keller A, Ballester O, Kovacs MJ, Blacklock HA, Bell R, Simeone J, Reitsma DJ, Heffeman M, Seaman J, Knight RD for the Myeloma Aredia Study Group (1996) Efficacy of Pamidronate in reducing skeletal events in patients with advanced multiple myeloma. N Engl J Med, 334, 488-493.
39. Moulopoulos LA, Varma DGK, Dimopoulos MA, Leeds NE, Kirn EE, Johnston DA, Alexanian R, Libshitz HI (1992) Multiple myeloma : spinal MR imaging in patients with untreated newly diagnosed disease. Radiology, 185, 833-839.
40. Tertti, R., Alanen, A., Remes, K. (1995) The value of magnetic resonance imaging in screening myeloma lesions of the lumbar spine. Br J Haematol, 91, 658-660.
41. Moulopoulos LA, Dimopoulos MA, Smith TL, Weber DM, Delasalle KB, Libshitz HI, Alexanian R (1995) Prognostic significance of magnetic resonance imaging in patients with asymptomatic multiple myeloma. J Clin Oncol, 13, 251-256.
42. Pilarski ML, Andrews EJ, Serra HM, Ledbetter JA, Ruether BA, Mant MJ (1989) Abnormalities in lymphocyte profile and specificity repertoire of patients with Waldenstrom's macroglobulinemia, multiple myeloma, and IgM monoclonal gammopathy of undetermined significance. Am J Hematol, 30, 53-60.